MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
3.885
-0.105
-2.63%
Opening 10:53 11/16 EST
OPEN
3.950
PREV CLOSE
3.990
HIGH
3.970
LOW
3.865
VOLUME
112.98K
TURNOVER
--
52 WEEK HIGH
9.94
52 WEEK LOW
3.565
MARKET CAP
234.92M
P/E (TTM)
-0.8415
1D
5D
1M
3M
1Y
5Y
1D
Vanda Pharmaceuticals Earnings Call Signals Growth Amid Risks
TipRanks · 1d ago
Corbus Pharmaceuticals Holdings Inc. Stock Sheds 14.8%, Underperforms Peers
Dow Jones · 3d ago
NEREUS™ - The Goat of Biscayne Bay Arrives for Miami Art Week
PR Newswire · 5d ago
Corbus Pharmaceuticals Holdings Inc. Stock Advances 11.6%, Outperforms Peers
Dow Jones · 5d ago
Corbus Pharmaceuticals Holdings Inc. Stock Rises 14.7%, Outperforms Peers
Dow Jones · 6d ago
Weekly Report: what happened at VNDA last week (1102-1106)?
Weekly Report · 11/09 09:13
Corbus Pharmaceuticals Holdings Inc. Stock Rises 7.3%, Outperforms Peers
Dow Jones · 11/06 21:34
Corbus Pharmaceuticals Holdings Inc. Stock Slides 19.9%, Underperforms Peers
Dow Jones · 11/05 21:32
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company, which is focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company's commercial portfolio consist of four products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome, PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS) including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease , and NEREUS for the prevention of vomiting induced by motion. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.